0001493152-19-016091.txt : 20191029 0001493152-19-016091.hdr.sgml : 20191029 20191029150450 ACCESSION NUMBER: 0001493152-19-016091 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191029 EFFECTIVENESS DATE: 20191029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new CENTRAL INDEX KEY: 0001022899 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061390025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352091 FILM NUMBER: 191176052 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 994-8200 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Atrinsic, Inc. DATE OF NAME CHANGE: 20090630 FORMER COMPANY: FORMER CONFORMED NAME: NEW MOTION, INC. DATE OF NAME CHANGE: 20070504 FORMER COMPANY: FORMER CONFORMED NAME: MPLC, Inc. DATE OF NAME CHANGE: 20050608 D 1 primary_doc.xml X0708 D LIVE 0001022899 Protagenic Therapeutics, Inc.\new 149 FIFTH AVENUE, SUITE 500 NEW YORK NY NEW YORK 10010 212-994-8200 DELAWARE New Motion, Inc. Atrinsic, Inc. NEW MOTION, INC. MPLC, Inc. Corporation true Garo H Armen 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Executive Officer Director Robert B Stein 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Director Khalil Barrage 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Director Joshua Silverman 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Director Brian J Corvese 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Director Alexander K Arrow 149 Fifth Avenue, Suite 500 New York NY NEW YORK 10010 Executive Officer Biotechnology Decline to Disclose 06b false true false true true false 0 2500000 0 2500000 Includes $500,000 principal amount of convertible notes which may be sold in the event the offering is over-subscribed. false 0 0 0 0 false Protagenic Therapeutics, Inc.\new /s/ Alexander K. Arrow Alexander K. Arrow Chief Financial Officer 2019-10-29